Insider Transactions in Q3 2023 at Health Catalyst, Inc. (HCAT)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 15
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,160
-1.41%
|
$12,760
$11.01 P/Share
|
Sep 06
2023
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,197
-3.72%
|
$24,167
$11.65 P/Share
|
Sep 06
2023
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
1,157
-3.94%
|
$12,727
$11.52 P/Share
|
Sep 01
2023
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,460
-4.72%
|
$93,060
$11.78 P/Share
|
Sep 01
2023
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
929
-1.55%
|
$10,219
$11.78 P/Share
|
Sep 01
2023
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,484
-1.78%
|
$16,324
$11.78 P/Share
|
Sep 01
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,128
-1.73%
|
$45,408
$11.78 P/Share
|
Sep 01
2023
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,103
-0.78%
|
$78,133
$11.78 P/Share
|
Sep 01
2023
|
Anne Marie Bickmore COO and Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,682
-2.42%
|
$18,502
$11.78 P/Share
|
Sep 01
2023
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
500
-1.68%
|
$5,500
$11.78 P/Share
|
Aug 22
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
737
-0.87%
|
$8,107
$11.9 P/Share
|
Jul 07
2023
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
1,179
-3.8%
|
$12,969
$11.14 P/Share
|